ARTL (Artelo Biosciences) Cyclically Adjusted Book per Share: $104.14 (As of Mar. 2026)


ARTL Artelo Biosciences Inc ARTL
31 GF Score
Price $1.13
! 2 Warning Signs
View Full Analysis

What is Artelo Biosciences Cyclically Adjusted Book per Share?

Artelo Biosciences ARTL -1.75% 31 Cyclically Adjusted Book per Share is $104.14 as of Mar. 2026. GuruFocus rates ARTL with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Artelo Biosciences's adjusted book value per share for the three months ended in Mar. 2026 was $7.616. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $104.14 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Artelo Biosciences's average Cyclically Adjusted Book Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-06-27), Artelo Biosciences's current stock price is $1.125. Artelo Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $104.14. Artelo Biosciences's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Artelo Biosciences was 0.01. The lowest was 0.00. And the median was 0.00.


Artelo Biosciences  (NAS:ARTL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Artelo Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.125/104.14
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Artelo Biosciences was 0.01. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Artelo Biosciences Cyclically Adjusted Book per Share Related Terms


Artelo Biosciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Artelo Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artelo Biosciences Cyclically Adjusted Book per Share Chart

Artelo Biosciences Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 101.12 99.75 101.98

Artelo Biosciences Quarterly Data
May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.11 101.72 102.27 101.98 104.14

ARTL vs RNAZ, GLMD, DCOY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Artelo Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artelo Biosciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artelo Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Artelo Biosciences's Cyclically Adjusted PB Ratio falls into.


ARTL
31GF Score
Artelo Biosciences Inc ARTL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artelo Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Artelo Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.616/330.2130*330.2130
=7.616

Current CPI (Mar. 2026) = 330.2130.

Artelo Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201605 -2.250 240.229 -3.093
201608 -3.500 240.849 -4.799
201611 -1.500 241.353 -2.052
201702 -4.750 243.603 -6.439
201705 -22.800 244.733 -30.764
201708 109.000 245.519 146.601
201711 58.800 246.669 78.715
201802 64.167 248.991 85.099
201805 -15.167 251.588 -19.907
201808 -22.500 252.146 -29.466
201811 -67.857 252.038 -88.904
201902 -98.857 252.776 -129.141
201905 16.750 256.092 21.598
201908 455.083 256.558 585.732
201911 381.769 257.208 490.129
202002 285.231 258.678 364.109
202005 230.357 256.394 296.680
202008 215.278 259.918 273.500
202011 161.679 260.229 205.160
202102 156.780 263.014 196.837
202105 138.558 269.195 169.965
202108 132.330 273.567 159.731
202111 180.166 277.948 214.044
202203 164.204 287.504 188.597
202206 150.873 296.311 168.135
202209 137.755 296.808 153.259
202212 122.031 296.797 135.770
202303 110.931 301.836 121.360
202306 102.314 305.109 110.732
202309 82.830 307.789 88.865
202312 66.395 306.746 71.474
202403 53.279 312.332 56.329
202406 40.777 314.175 42.859
202409 35.536 315.301 37.217
202412 15.116 315.605 15.816
202503 3.450 319.799 3.562
202506 -5.983 322.561 -6.125
202509 -1.222 324.800 -1.242
202512 -1.890 324.054 -1.926
202603 7.616 330.213 7.616

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $104.14 mean?
Artelo Biosciences (ARTL) has a Cyclically Adjusted Book per Share of $104.14 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Artelo Biosciences and its competitors.
Is Artelo Biosciences' Cyclically Adjusted Book per Share too high?
Artelo Biosciences' current Cyclically Adjusted Book per Share is $104.14. Overall, Artelo Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Artelo Biosciences' Cyclically Adjusted Book per Share compare to RNAZ and GLMD?
Artelo Biosciences' Cyclically Adjusted Book per Share of $104.14 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Artelo Biosciences and its competitors. Artelo Biosciences's current Cyclically Adjusted Book per Share is $104.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artelo Biosciences stock overvalued right now?
Artelo Biosciences (ARTL) has a current Cyclically Adjusted Book per Share of $104.14. The current Cyclically Adjusted Book per Share is $104.14. Artelo Biosciences' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Artelo Biosciences (ARTL), the current Cyclically Adjusted Book per Share is $104.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artelo Biosciences Business Description

Address 505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
31GF Score

Get the complete analysis for ARTL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price